Showing 5,845 results

Filters Content type: News, Editors' picks Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

Treatment for women

Darunavir/ritonavir as effective in women as men

News
22 September 2010
New & experimental HIV treatments

Cytheris initiates INSPIRE 3, a phase II clinical trial of recombinant human interleukin-7 (CYT107) in chronically infected HIV patients

Editor's pick
Cytheris
22 September 2010
Hepatitis C treatment

Taribavirin offers a safe, effective alternative for chronic hepatitis C

Editor's pick
Eurekalert Medicine & Health
22 September 2010
How HIV works

Scientists reveal HIV cell mystery

Editor's pick
The Age
21 September 2010
Adherence

Longer viral load is undetectable, lower the risk of rebound

News
20 September 2010
Changing treatment

Switch to nevirapine can happen at any CD4 count, says European drug regulator

News
17 September 2010
New & experimental HIV treatments

ICAAC: Novel HIV drug a 'trade-off'

Editor's pick
MedPage Today
17 September 2010
New & experimental HIV treatments

Poor adherence, high viral loads help explain rilpivirine treatment failures

Editor's pick
AIDSMeds.com
17 September 2010
Drug interactions & pharmacokinetics

Raltegravir Pharmacokinetics Disrupted by Antacids in Healthy Patients With HIV: Presented at ICAAC

Editor's pick
Doctor's Guide
16 September 2010
New & experimental HIV treatments

ICAAC: Study Closes Vicriviroc Story

Editor's pick
MedPage Today
16 September 2010
Cardiovascular disease

ICAAC: Switch to HIV combo pill may improve lipids

Editor's pick
MedPage Today
16 September 2010
New & experimental HIV treatments

GSK new NNRTI selects no resistance mutations in 7 days of monotherapy

Editor's pick
NATAP
16 September 2010
New & experimental HIV treatments

K.U.Leuven enters license agreement with Pfizer to commercialize anti-HIV drugs

Editor's pick
News-Medical-Net
16 September 2010
New & experimental HIV treatments

New NRTI festinavir exhibits good anti-HIV activity and safety in phase 1b/2a study

Editor's pick
HIVandhepatitis.com
15 September 2010
New & experimental HIV treatments

Elvitegravir "Quad" single-tablet regimen shows continued HIV suppression at 48 weeks

Editor's pick
HIVandhepatitis.com
15 September 2010
Hepatitis C treatment

HIV/HCV co-infected women more likely to stop HCV therapy

News
14 September 2010
Money

Stipends go - so HIV patients refuse drugs

Editor's pick
The Sowetan
10 September 2010
Treatment guidelines

India not treating AIDS patients early: Global Fund

Editor's pick
Reuters
9 September 2010
Resistance

AFRICA: Drug-resistant HIV threat looming

Editor's pick
IRIN Plus News
9 September 2010
PEP

Truvada/Kaletra HIV PEP combination is safe and effective with a low rate of discontinuations

News
9 September 2010
Undetectable viral load & treatment as prevention

High genital HIV levels may persist in women who appear to achieve viral suppression with use of ART

News
6 September 2010
New & experimental HIV treatments

Gilead Sciences submits European marketing application for once-daily single-tablet regimen of Truvada(R) and TMC278 for the treatment of HIV infection

Editor's pick
Market Watch
3 September 2010
Pregnancy and vertical transmission

Botswana: HIV-positive mothers not convinced to exclusively breastfeed

Editor's pick
IPS
2 September 2010
New & experimental HIV treatments

AIDS cure quest to kill `sleeping' viruses enlists Merck cancer medicine

Editor's pick
Bloomberg
2 September 2010